D31.5
Benign neoplasm of lacrimal gland and duct
Clinical Classification Guidelines
Inclusion Terms
- Benign neoplasm of lacrimal sac
- Benign neoplasm of nasolacrimal duct
Medical Intelligence & Overview
Benign neoplasm of the lacrimal gland and duct, classified under ICD-10 code D31.5, refers to non-cancerous tumors that develop in the tissues of the lacrimal gland, which produces tears, or its associated ducts. These growths are typically slow-growing and do not spread to other parts of the body. They may involve the lacrimal sac and the nasolacrimal duct, which are parts of the tear drainage system. While benign, these tumors can cause discomfort or affect tear drainage, leading to various ocular symptoms.
Causes & Symptoms
Clinical Causes: Genetic factors that predispose individuals to benign tumors Chronic inflammation of the lacrimal gland or duct Previous infections affecting the tear drainage system Unknown environmental or lifestyle factors
Key Symptoms: A noticeable lump or swelling near the outer corner of the eye Discomfort or a feeling of fullness in the affected area Increased tearing (epiphora) Reduced tear drainage leading to watery eyes Rarely, blurred vision or ocular irritation if the growth presses on surrounding structures
Diagnostic & Treatment
Diagnosis Path: Diagnosis of benign neoplasm of the lacrimal gland and duct typically involves a combination of clinical evaluation and imaging studies. An ophthalmologist or an oculoplastic specialist examines the eye and adjacent tissues for swelling or masses. Imaging techniques such as ultrasound, MRI, or CT scans help visualize the extent of the tumor and differentiate benign from malignant growths. In some cases, a biopsy may be performed to confirm the benign nature of the tumor.
Treatment Protocols: Management strategies depend on the size, location, and symptoms caused by the tumor. Common treatment options include: - Observation: Monitoring small, asymptomatic tumors for any changes over time. - Surgical removal: Excision of the tumor through specialized techniques to preserve eye and tear drainage function. - Addressing associated symptoms: Such as managing tearing or discomfort. Postoperative follow-up is essential to detect any recurrence or complications. In some cases, additional treatments might be necessary if the tumor causes significant functional impairment.
Clinical Advice & FAQs
Billing Guidance
Is D31.5 a billable ICD-10 code?
Yes, D31.5 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D31.5?
Clinical documentation must specify the nature of Benign neoplasm of lacrimal gland and duct and any associated comorbidities for accurate reporting.
Cite this Clinical Reference